AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8127531
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive (20 micrograms ethinyl estradiol plus 0.15 mg desogestrel)
Trial: 2758778
Drug: ADFR therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADFR therapy (phosphorus 1.5 gr/day during 3 days, followed by SCT 100 UI/day during 10 days and calcium 1 gr/day)
Trial: 28326899
Drug: Complementary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary and alternative medicines (CAM) and non‐pharmacological interventions (NPI)
Trial: 11923030
Drug: Herbal therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal therapies
Trial: 28326899
Drug: Higher education,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher education, Black ethnicity, MHT or previous oral contraceptive pill use
Trial: 23083114
Drug: Phenylbutazone (PBZ)
RxNorm normalized name: Phenylbutazone
DrugBank: Phenylbutazone (DB00812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylbutazone (PBZ) at 4.4 mg/kg PO q12h day 1, 2.2 mg/kg PO q12h for 4 days, 2.2 mg/kg PO q24h for 9 days
Trial: 23083114
Drug: Meloxicam at
RxNorm normalized name: Meloxicam
DrugBank: Meloxicam (DB00814)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meloxicam at 0.6 mg/kg q24h, 1.8 mg/kg q24h, 3.0 mg/kg q24h
Trial: 17706714
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (300 mg orally twice daily)
Trial: 17706714
Drug: Propionyl-L-carnitine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine (1 gm orally twice daily)
Trial: 17706714
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E plus Propionyl-L-carnitine (300 mg and 1 gm orally twice daily)
Trial: 11520815
Drug: Thalidomide with
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide with induction chemotherapy
Trial: 11520815
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (induction chemotherapy without thalidomide)
Trial: 7526468
Drug: Vinorelbine in
RxNorm normalized name: vinorelbine Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine in combination with cisplatin
Trial: 2890666
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg nocturnal dosing
Trial: 2890666
Drug: Nizatidine 300
RxNorm normalized name: nizatidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 300 mg nocturnal dosing
Trial: 29947833
Drug: Intravenous tirofiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tirofiban injection and tirofiban injection via a TA catheter to the infarcted coronary artery after aspiration (Group A)
Trial: 29947833
Drug: Intravenous tirofiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tirofiban injection only (Group B)
Trial: 24667994
Drug: Bimatoprost 0.03%/timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost 0.03%/timolol 0.5% preservative-free (PF) ophthalmic solution
Trial: 24667994
Drug: Bimatoprost 0.03%/timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost 0.03%/timolol 0.5% ophthalmic solution
Trial: 12870162
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (metformin 400 to 2,400 mg/d + glibenclamide 2.5 to 15 mg/d)
Trial: 12870162
Drug: Metformin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin alone (500 to 3,000 mg/d)
Trial: 12870162
Drug: Glibenclamide alone
RxNorm normalized name: glibenclamide
DrugBank: Glyburide (DB01016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glibenclamide alone (5 to 15 mg/d)
Trial: 12870162
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment vs Metformin alone
Trial: 12870162
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment vs Glibenclamide alone
Trial: 10510105
Drug: SR alfuzosin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR alfuzosin (5 mg twice daily)
Trial: 9071060
Drug: Traditional drug
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional drug abuse prevention program activities
Trial: 1568518
Drug: Rifamycin SV
RxNorm normalized name: rifamycin SV
DrugBank: Rifamycin (DB11753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifamycin SV (525 mg weekly for 10 weeks)
Trial: 1568518
Drug: Pefloxacin (560
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pefloxacin (560 mg weekly for 10 weeks)
Trial: 3902550
Drug: Golytely preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Golytely preparation
Trial: 27268605
Drug: Standard interferon
RxNorm normalized name: INTERFERON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard interferon (IFN) therapy combined with ribavirin (3 MIU three times a week and 800-1200 mg/day) for six months
Trial: 12783630
Drug: Propranolol CR
RxNorm normalized name: propranolol Extended Release Oral Capsule [Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol CR (Innopran XL) 160 mg single dose at 10 pm
Trial: 12783630
Drug: Sustained-release propranolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release propranolol, single dose
Trial: 12783630
Drug: Propranolol CR
RxNorm normalized name: propranolol Extended Release Oral Capsule [Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol CR and sustained-release propranolol, multiple dosing
Trial: 12783630
Drug: Propranolol CR
RxNorm normalized name: propranolol Extended Release Oral Capsule [Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol CR and sustained-release propranolol, final dose
Trial: 12783630
Drug: Propranolol CR
RxNorm normalized name: propranolol Extended Release Oral Capsule [Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol CR and sustained-release propranolol, bioavailability
Trial: 8784645
Drug: Venlafaxine (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (dosage not specified, administered twice or three times daily)
Trial: 1312853
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg, twice daily for 5 days (pretreatment)
Trial: 6547414
Drug: Sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (1 g 4 times daily for 8 weeks)
Trial: 6547414
Drug: Carbenoxolone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenoxolone (50 mg 4 times daily for 8 weeks)
Trial: 28939682
Drug: Pioglitazone (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (target 45 mg daily)
Trial: 25233652
Drug: Jin three-needle
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jin three-needle therapy combined with MOTOmed intelligent motor training
Trial: 19424890
Drug: Direct intensive
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct intensive speech and language therapy weekly over an 8-month period
Trial: 10398549
Drug: Intensive blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive blood glucose control using sulphonylureas or insulin therapy or metformin in overweight patients
Trial: 10398549
Drug: Drugs or
RxNorm normalized name: herbal drugs ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs or insulin used for blood glucose control
Trial: 7769811
Drug: bisoprolol (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bisoprolol (single oral dose)
Trial: 6307777
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml of fresh human milk per day
Trial: 31082899
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy
Trial: 27320956
Drug: Cardiac Resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Trial: 15791520
Drug: Indinavir (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir (500 mg/m2 every 8 hours)
Trial: 15791520
Drug: Ritonavir (liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir (liquid formulation)
Trial: 11929641
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) with 50 microg ethinyl estradiol (EE)
Trial: 11929641
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) with 30-40 microg ethinyl estradiol (EE)
Trial: 11929641
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) with 20 microg ethinyl estradiol (EE)
Trial: 11929641
Drug: Progestin-only pills
RxNorm normalized name: Prostin E2 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progestin-only pills
Trial: 11929641
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives with second-generation progestins (levonorgestrel or norgestimate) and 20-30 microg EE
Trial: 11929641
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives with third-generation progestins (desogestrel or gestodene) and 20-30 microg EE
Trial: 10212716
Drug: Sub-Tenon's block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-Tenon's block with 2% lignocaine 1 ml containing 150 i.u. per ml of hyaluronidase with 2% plain lignocaine 2 ml and 0.5% plain bupivacaine 2 ml
Trial: 10212716
Drug: Sub-Tenon's block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-Tenon's block with 2% plain lignocaine 3 ml with 0.5% plain bupivacaine 2 ml
Trial: 8540977
Drug: Standard supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard supplements (for groups 1 and 2)
Trial: 8540977
Drug: Increased supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased supplements (group 3)
Trial: 2215985
Drug: Propofol 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1.5 mg/kg and Ketamine 1 mg/kg i.v.
Trial: 2215985
Drug: Propofol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.5 mg/kg and Fentanyl 1.5 micrograms/kg
Trial: 7000226
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of metronidazole intra-rectally 1 h preoperatively
Trial: 31192722
Drug: Music Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Therapy (n = 16)
Trial: 28693614
Drug: Increasing access
RxNorm normalized name: sofosbuvir
DrugBank: Sofosbuvir (DB08934)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Increasing access to treatment
Trial: 17967712
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oxidized regenerated cellulose/collagen biomaterial and autologous growth factors
Trial: 23391845
Drug: Pharmacist intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist intervention program including education on medication adherence and hypertension, and provision of a home blood pressure monitoring device.
Trial: 9166129
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg oral DMSA
Trial: 1540053
Drug: Transfer factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfer factor (1 mL at 3-month intervals after operation)
Trial: 29154132
Drug: Dexmedetomidine (1-μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1-μg/kg over 10 min)
Trial: 29154132
Drug: Dexmedetomidine (0.5-μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.5-μg/kg over 10 min)
Trial: 24903511
Drug: Atorvastatin reload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin reload
Trial: 22614920
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate nasal spray (FFNS) 110 μg once daily
Trial: 22614920
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate nasal spray (FFNS) 110 μg twice daily
Trial: 15827692
Drug: gel
RxNorm normalized name: Gel
DrugBank: Sepia esculenta bone (DB16562)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gel
Trial: 15827692
Drug: carmellose spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: carmellose spray
Trial: 15827692
Drug: mucin spray
RxNorm normalized name: mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mucin spray
Trial: 10636527
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of diuretics (<80 mg/day of furosemide)
Trial: 10636527
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of diuretics (>=80 mg/day of furosemide)
Trial: 10636527
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment with diuretics prior to hospitalization
Trial: 28584913
Drug: Triazolam 0.125
RxNorm normalized name: triazolam 0.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.125 mg
Trial: 28203729
Drug: Liberal group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal group (LG) - early postoperative oral fluid intake with apple juice (10 ml kg−1) offered if FLACC score ≥4 in PACU
Trial: 19811503
Drug: frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: frovatriptan 2.5 mg b.i.d.
Trial: 19811503
Drug: frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: frovatriptan 2.5 mg q.d.
Trial: 12135535
Drug: 20 mg/d
RxNorm normalized name: Valtoco, 20 mg/dose nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/d fluoxetine
Trial: 17074147
Drug: One tablet
RxNorm normalized name: Hydone Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One tablet of almitrine l/d and 20 mg oryzanol 3/d
Trial: 17074147
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antidepressant treatment)
Trial: 15447755
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg plus Isosorbide-5-mononitrate 20 mg
Trial: 11588526
Drug: Pravastatin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin, 40 mg/day for 6 months
Trial: 9842024
Drug: Pemirolast potassium
RxNorm normalized name: Pemirolast Potassium
DrugBank: Pemirolast (DB00885)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pemirolast potassium (20 mg/d from 1 week before PTCA until follow-up angiography at 4 months)
Trial: 1101943
Drug: Automatic Cardiff
RxNorm normalized name: AMMONIA,AROMATIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic Cardiff Infusion apparatus for PGE2
Trial: 1101943
Drug: Non-automatic techniques
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-automatic techniques for PGE2 and oxytocin infusion
Trial: 3034795
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for relapsed patients
Trial: 28158579
Drug: Bevacizumab-paclitaxel (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab-paclitaxel (10 mg/kg bevacizumab on Days 1 and 15, paclitaxel 90 mg/m2 on Days 1, 8, and 15, repeated every 4 weeks)
Trial: 28158579
Drug: Placebo-paclitaxel (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-paclitaxel (placebo on Days 1 and 15, paclitaxel 90 mg/m2 on Days 1, 8, and 15, repeated every 4 weeks)
Trial: 25509728
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment group
Trial: 21164065
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg i.v. ibuprofen (infused over five to seven minutes)
Trial: 21164065
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection)
Trial: 21164065
Drug: i.v. ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ibuprofen
Trial: 18640378
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of BBR (90 mg/[kg d], oral) with SIMVA (6 mg/[kg d], oral)
Trial: 18640378
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of BBR with SIMVA
Trial: 18640378
Drug: SIMVA (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIMVA (6 mg/[kg d], oral)
Trial: 16522699
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (CEE; 0.625 mg) with 2.5 mg medroxyprogesterone acetate (MPA)
Trial: 12667032
Drug: Thiazide diuretics,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide diuretics, angiotensin II receptor blockers, ACE inhibitors
Trial: 12667032
Drug: Beta-blockers and
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers and calcium-channel blockers
Trial: 1654240
Drug: 3 million
RxNorm normalized name: INTERFERON GAMMA-1B 3 MILLION UNT/0.5ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 million units of recombinant human alpha-interferon (alpha-2a) thrice weekly for eight weeks
Trial: 6137646
Drug: Live oral
RxNorm normalized name: Cholera Vaccine Live Oral
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live oral attenuated bovine rotavirus vaccine strain RIT 4237
Trial: 24593170
Drug: CZP 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CZP 200 mg every other week plus methotrexate
Trial: 24593170
Drug: CZP 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CZP 400 mg every 4 weeks plus methotrexate
Trial: 17593406
Drug: Whitestrips (WS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whitestrips (WS) - 6% hydrogen peroxide gel, applied twice a day for 30 min
Trial: 17593406
Drug: Vivadent Vivastyle
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vivadent Vivastyle (VS) - 10% carbamide peroxide gel, worn for 60 min once a day
Trial: 3105906
Drug: Buserelin (d‐Ser‐[TBU]6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (d‐Ser‐[TBU]6 LHRH ethylamide) prescribed in two different dosage schedules to twenty men and in a single dosage schedule to eight women
Trial: 30287704
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Tell Show Do (TSD) and Audiovisual Distraction (AVD)
Trial: 19043140
Drug: Rosuvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (40 mg/day)
Trial: 17183151
Drug: Pravastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (80 mg/day)
Trial: 17006995
Drug: Senna tablet
DrugBank: Senna leaf (DB15889)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna tablet (180 mg)
Trial: 17006995
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate solution (95 mL)
Trial: 10781196
Drug: Subcutaneous Havrix(R)
RxNorm normalized name: Havrix
DrugBank: Hepatitis A Vaccine (DB10989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous Havrix(R) vaccine, 720 EL.U. at time 0 and 6 months
Trial: 10781196
Drug: Subcutaneous Havrix(R)
RxNorm normalized name: Havrix
DrugBank: Hepatitis A Vaccine (DB10989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous Havrix(R) vaccine
Trial: 10781196
Drug: Intramuscular Havrix(R)
RxNorm normalized name: Havrix
DrugBank: Hepatitis A Vaccine (DB10989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular Havrix(R) vaccine, 720 EL.U. at time 0 and 6 months
Trial: 10781196
Drug: Intramuscular Havrix(R)
RxNorm normalized name: Havrix
DrugBank: Hepatitis A Vaccine (DB10989)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular Havrix(R) vaccine
Trial: 1591977
Drug: Naloxone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10 mg/70 kg) after morphine (4 mg/70 kg)
Trial: 1591977
Drug: Naloxone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10 mg/70 kg) after morphine (8 mg/70 kg)